TABLE 3.

Odds ratios of new-onset LEPAD by 10-year China-PAR ASCVD risk.

Variables	Crude model		Adjusted model I		Adjusted model II
	OR (95% CI)	P-value	OR (95% CI)	P-value	OR (95% CI)	P-value
10-year ASCVD risk, per 1%
	1.06 (1.03, 1.08)	<0.001	1.11 (1.07, 1.15)	<0.001	1.09 (1.05, 1.12)	<0.001
10-year ASCVD risk groups, %
<5	1.00		1.00		1.00
5–<10	0.77 (0.49, 1.21)	0.251	1.05 (0.62, 1.76)	0.868	0.93 (0.56, 1.54)	0.783
≥10	2.27 (1.58, 3.27)	<0.001	4.15 (2.27, 7.59)	<0.001	3.36 (2.02, 5.58)	<0.001
<10	1.00		1.00		1.00
≥10	2.46 (1.74, 3.46)	<0.001	4.03 (2.43, 6.69)	<0.001	3.48 (2.23, 5.42)	<0.001

CI, confidence interval; OR, odds ratio; LEPAD, lower extremity peripheral artery disease; ASCVD, atherosclerotic cardiovascular disease; eGFR, estimated glomerular filtration rate.

Model I: adjusted for baseline ABI, sex, and age.

Model II: adjusted for variables not used to calculating the China-PAR risk including baseline ABI, BMI, current drinking, hypertension, dyslipidemia, eGFR groups, antihypertensive agents, lipid-lowering agents, and hypoglycemic agents.